Skip to main content
Erschienen in: Current Urology Reports 6/2012

01.12.2012 | Benign Prostatic Hyperplasia (K McVary, Section Editor)

The Impact of Prostate Biopsy on Urinary Symptoms, Erectile Function, and Anxiety

verfasst von: Alexander P. Glaser, Kristian Novakovic, Brian T. Helfand

Erschienen in: Current Urology Reports | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Transrectal ultrasound-guided prostate needle biopsy (PB) is considered the gold standard for the diagnosis of prostate cancer. Recently, lower urinary tract symptoms and erectile dysfunction have been reported following PB. We reviewed the literature on PB and these symptoms and summarized known findings between these conditions and other variables, such as periprostatic nerve block, saturation biopsy, serial biopsies, and psychological factors associated with PB and cancer. A PubMed search was performed using keywords “prostate biopsy,” “complications,” “erectile dysfunction,” “lower urinary tract symptoms,” “anxiety,” and “quality of life.” Eleven key papers are discussed and personal experience is drawn upon. Based upon available evidence, PB appears to be associated with short-term exacerbation of urinary symptoms in some men, as well as associated with anxiety and temporary erectile dysfunction, without a distinct relationship to periprostatic nerve block or the number of cores biopsied. Additional studies are warranted to determine the definitive etiology of these symptoms and to determine if interventions could reduce patient morbidity. In the interim, patients should be educated and counseled about these risks before undergoing PB.
Literatur
1.
Zurück zum Zitat Hodge KK, McNeal JE, Stamey TA. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol. 1989;142(1):66–70.PubMed Hodge KK, McNeal JE, Stamey TA. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol. 1989;142(1):66–70.PubMed
2.
Zurück zum Zitat Hodge KK, et al. Random systematic vs directed ultrasound guided transrectal core biopsies of the prostate. J Urol. 1989;142(1):71–4.PubMed Hodge KK, et al. Random systematic vs directed ultrasound guided transrectal core biopsies of the prostate. J Urol. 1989;142(1):71–4.PubMed
3.
Zurück zum Zitat Bostwick DG, Meiers I. Prostate biopsy and optimization of cancer yield. Eur Urol. 2006;49(3):415–7.PubMedCrossRef Bostwick DG, Meiers I. Prostate biopsy and optimization of cancer yield. Eur Urol. 2006;49(3):415–7.PubMedCrossRef
4.
Zurück zum Zitat Djavan B, et al. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol. 2001;166:856–60.PubMedCrossRef Djavan B, et al. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol. 2001;166:856–60.PubMedCrossRef
5.
Zurück zum Zitat Raaijmakers R, et al. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology. 2002;60(5):826–30.PubMedCrossRef Raaijmakers R, et al. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology. 2002;60(5):826–30.PubMedCrossRef
6.
Zurück zum Zitat Berger AP, et al. Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores. J Urol. 2004;171(4):1478–81.PubMedCrossRef Berger AP, et al. Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores. J Urol. 2004;171(4):1478–81.PubMedCrossRef
7.
Zurück zum Zitat Yu JH, et al. Evaluation of the risk factors for complications after prostate needle biopsy. Eur Urol Suppl. 2010;9(2):84–5.CrossRef Yu JH, et al. Evaluation of the risk factors for complications after prostate needle biopsy. Eur Urol Suppl. 2010;9(2):84–5.CrossRef
8.
Zurück zum Zitat Stewart CS, et al. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol. 2001;166(1):91–2.CrossRef Stewart CS, et al. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol. 2001;166(1):91–2.CrossRef
9.
Zurück zum Zitat Fleshner N, Klotz L. Role of "saturation biopsy" in the detection of prostate cancer among difficult diagnostic cases. Urology. 2002;60:93–7.PubMedCrossRef Fleshner N, Klotz L. Role of "saturation biopsy" in the detection of prostate cancer among difficult diagnostic cases. Urology. 2002;60:93–7.PubMedCrossRef
10.
Zurück zum Zitat Boccon-Gibod LM, et al. Prostate saturation biposy in the reevalation of microfocal prostate cancer. J Urol. 2006;176:961–3.PubMedCrossRef Boccon-Gibod LM, et al. Prostate saturation biposy in the reevalation of microfocal prostate cancer. J Urol. 2006;176:961–3.PubMedCrossRef
11.
Zurück zum Zitat Ashley RA, et al. Reassessing the diagnostic yield of saturation biopsy of the prostate. Eur Urol. 2008;53(5):976–83.PubMedCrossRef Ashley RA, et al. Reassessing the diagnostic yield of saturation biopsy of the prostate. Eur Urol. 2008;53(5):976–83.PubMedCrossRef
12.
Zurück zum Zitat Rosen RC, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–30.PubMedCrossRef Rosen RC, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49:822–30.PubMedCrossRef
13.
Zurück zum Zitat Cappelleri JC, et al. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology. 1999;54:346–51.PubMedCrossRef Cappelleri JC, et al. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology. 1999;54:346–51.PubMedCrossRef
14.
Zurück zum Zitat Rosen RC, et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res.1999. 1999 (11). Rosen RC, et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res.1999. 1999 (11).
15.
Zurück zum Zitat Barry MJ, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148(5):1549–57.PubMed Barry MJ, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148(5):1549–57.PubMed
16.
Zurück zum Zitat Zisman A, et al. The impact of prostate biopsy on patient well-being: a prospective study of voiding impairment. J Urol. 2001;166:2242–6.PubMedCrossRef Zisman A, et al. The impact of prostate biopsy on patient well-being: a prospective study of voiding impairment. J Urol. 2001;166:2242–6.PubMedCrossRef
17.
Zurück zum Zitat Zisman A, et al. The impact of prostate biopsy on patient well-being: a prospective study of pain, anxiety and erectile dysfunction. J Urol. 2001;165(2):445–54.PubMedCrossRef Zisman A, et al. The impact of prostate biopsy on patient well-being: a prospective study of pain, anxiety and erectile dysfunction. J Urol. 2001;165(2):445–54.PubMedCrossRef
18.
Zurück zum Zitat Bozlu M, et al. Voiding impairment after prostate biopsy: does tamsulosin treatment before biopsy decrease this morbidity? Urology. 2003;62:1050–3.PubMedCrossRef Bozlu M, et al. Voiding impairment after prostate biopsy: does tamsulosin treatment before biopsy decrease this morbidity? Urology. 2003;62:1050–3.PubMedCrossRef
19.
Zurück zum Zitat Chrisofos M, et al. Can prostate biopsies affect erectile function? Andrologia. 2006;38(3):79–83.PubMedCrossRef Chrisofos M, et al. Can prostate biopsies affect erectile function? Andrologia. 2006;38(3):79–83.PubMedCrossRef
20.
Zurück zum Zitat Berger AP, et al. Periprostatic administration of local anesthesia during transrectal ultrasound-guided biopsy of the prostate: a randomized, double-blind, placebo-controlled study. Urology. 2003;61(3):585–8.PubMedCrossRef Berger AP, et al. Periprostatic administration of local anesthesia during transrectal ultrasound-guided biopsy of the prostate: a randomized, double-blind, placebo-controlled study. Urology. 2003;61(3):585–8.PubMedCrossRef
21.
Zurück zum Zitat Öbek CAN, et al. Comparison of three different methods of anesthesia before transrectal prostate biopsy: a prospective randomized trial. J Urol. 2004;172(2):502–5.PubMedCrossRef Öbek CAN, et al. Comparison of three different methods of anesthesia before transrectal prostate biopsy: a prospective randomized trial. J Urol. 2004;172(2):502–5.PubMedCrossRef
22.
Zurück zum Zitat Tuncel A, et al. The impact of transrectal prostate needle biopsy on sexuality in men and their female partners. Urology. 2008;71(6):1128–31.PubMedCrossRef Tuncel A, et al. The impact of transrectal prostate needle biopsy on sexuality in men and their female partners. Urology. 2008;71(6):1128–31.PubMedCrossRef
23.
Zurück zum Zitat Aktoz T, et al. Multimodal approach to management of prostate biopsy pain and effects on sexual function: efficacy of levobupivacaine adjuvant to diclofenac sodiujm—a prospective randomized trial. Andrologia. 2009;42:35–40.CrossRef Aktoz T, et al. Multimodal approach to management of prostate biopsy pain and effects on sexual function: efficacy of levobupivacaine adjuvant to diclofenac sodiujm—a prospective randomized trial. Andrologia. 2009;42:35–40.CrossRef
24.
Zurück zum Zitat • Klein T, et al. The impact of prostate biopsy and periprostatic nerve block on erectile and voiding function: a prospective study. J Urol. 2010;184(4):1447–52. This randomized trial found that prostate biopsy may cause urinary symptoms and erectile dysfunction, regardless of anesthesia or number of cores sampled.PubMedCrossRef • Klein T, et al. The impact of prostate biopsy and periprostatic nerve block on erectile and voiding function: a prospective study. J Urol. 2010;184(4):1447–52. This randomized trial found that prostate biopsy may cause urinary symptoms and erectile dysfunction, regardless of anesthesia or number of cores sampled.PubMedCrossRef
25.
Zurück zum Zitat Akyol I, Adayener C. Transient impotence after transrectal ultrasound-guided prostate biopsy. J Clin Ultrasound. 2008;36(1):33–4.PubMedCrossRef Akyol I, Adayener C. Transient impotence after transrectal ultrasound-guided prostate biopsy. J Clin Ultrasound. 2008;36(1):33–4.PubMedCrossRef
26.
Zurück zum Zitat Akbal C, et al. Erectile function in prostate cancer–free patients who underwent prostate saturation biopsy. Eur Urol. 2008;53(3):540–6.PubMedCrossRef Akbal C, et al. Erectile function in prostate cancer–free patients who underwent prostate saturation biopsy. Eur Urol. 2008;53(3):540–6.PubMedCrossRef
27.
Zurück zum Zitat Cooperberg MR, Carroll PR, Klotz L. Active surveillance for prostate cancer: progress and promise. J Clin Oncol. 2011;29(27):3669–76.PubMedCrossRef Cooperberg MR, Carroll PR, Klotz L. Active surveillance for prostate cancer: progress and promise. J Clin Oncol. 2011;29(27):3669–76.PubMedCrossRef
28.
Zurück zum Zitat Klotz L. Active surveillance for favorable-risk prostate cancer: background, patient selection, triggers for intervention, and outcomes. Curr Urol Rep. 2012;13(2):153–9.PubMedCrossRef Klotz L. Active surveillance for favorable-risk prostate cancer: background, patient selection, triggers for intervention, and outcomes. Curr Urol Rep. 2012;13(2):153–9.PubMedCrossRef
29.
Zurück zum Zitat • Fujita K, et al. Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance. J Urol. 2009;182(6):2664–9. This study demonstrated that men who undergo serial biopsies are at a higher risk for erectile dysfunction.PubMedCrossRef • Fujita K, et al. Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance. J Urol. 2009;182(6):2664–9. This study demonstrated that men who undergo serial biopsies are at a higher risk for erectile dysfunction.PubMedCrossRef
30.
31.
Zurück zum Zitat Macefield RC, et al. Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result. Br J Canc. 2010;102(9):1335–40.CrossRef Macefield RC, et al. Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result. Br J Canc. 2010;102(9):1335–40.CrossRef
32.
Zurück zum Zitat Mehnert A, et al. Depression, anxiety, post-traumatic stress disorder and health-related quality of life and its association with social support in ambulatory prostate cancer patients. Eur J Canc Care. 2010;19(6):736–45.CrossRef Mehnert A, et al. Depression, anxiety, post-traumatic stress disorder and health-related quality of life and its association with social support in ambulatory prostate cancer patients. Eur J Canc Care. 2010;19(6):736–45.CrossRef
33.
Zurück zum Zitat Sharpley CF, Christie DRH, Bitsika V. Variability in anxiety and depression over time following diagnosis in patients with prostate cancer. J Psychosoc Oncol. 2010;28(6):644–65.PubMedCrossRef Sharpley CF, Christie DRH, Bitsika V. Variability in anxiety and depression over time following diagnosis in patients with prostate cancer. J Psychosoc Oncol. 2010;28(6):644–65.PubMedCrossRef
34.
Zurück zum Zitat Franco EL, et al. Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: prospective cohort study. PLoS Medicine. 2009;6(12):e1000197.CrossRef Franco EL, et al. Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: prospective cohort study. PLoS Medicine. 2009;6(12):e1000197.CrossRef
35.
Zurück zum Zitat Bill-Axelson A, et al. Suicide risk in men with prostate-specific antigen–detected early prostate cancer: a nationwide population-based cohort study from pcbase sweden. Eur Urol. 2010;57(3):390–5.PubMedCrossRef Bill-Axelson A, et al. Suicide risk in men with prostate-specific antigen–detected early prostate cancer: a nationwide population-based cohort study from pcbase sweden. Eur Urol. 2010;57(3):390–5.PubMedCrossRef
36.
Zurück zum Zitat Fang F, et al. Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the united states. J Natl Canc Inst. 2010;102(5):307–14.CrossRef Fang F, et al. Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the united states. J Natl Canc Inst. 2010;102(5):307–14.CrossRef
37.
Zurück zum Zitat Brindle LA, et al. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK. BJU Int. 2006;98(4):777–82.PubMedCrossRef Brindle LA, et al. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK. BJU Int. 2006;98(4):777–82.PubMedCrossRef
38.
Zurück zum Zitat • Helfand BT, et al. Prostate cancer diagnosis is associated with an increased risk of erectile dysfunction after prostate biopsy. BJU Int. 2012. May 28. doi: 10.1111/j.1464–410X.2012.11268.x. [Epub ahead of print] This study found that men diagnosed with cancer had erectile dysfunction, while men with benign disease did not. • Helfand BT, et al. Prostate cancer diagnosis is associated with an increased risk of erectile dysfunction after prostate biopsy. BJU Int. 2012. May 28. doi: 10.​1111/​j.​1464–410X.​2012.​11268.​x. [Epub ahead of print] This study found that men diagnosed with cancer had erectile dysfunction, while men with benign disease did not.
39.
Zurück zum Zitat Hayes JH, et al. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA. 2010;304(21):2373–80.PubMedCrossRef Hayes JH, et al. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA. 2010;304(21):2373–80.PubMedCrossRef
40.
Zurück zum Zitat Burnet KL, et al. Does active surveillance for men with localized prostate cancer carry psychological morbidity? BJU Int. 2007;100(3):540–3.PubMedCrossRef Burnet KL, et al. Does active surveillance for men with localized prostate cancer carry psychological morbidity? BJU Int. 2007;100(3):540–3.PubMedCrossRef
41.
Zurück zum Zitat van den Bergh RCN, et al. Do anxiety and distress increase during active surveillance for low risk prostate cancer? J Urol. 2010;183(5):1786–91.PubMedCrossRef van den Bergh RCN, et al. Do anxiety and distress increase during active surveillance for low risk prostate cancer? J Urol. 2010;183(5):1786–91.PubMedCrossRef
42.
Zurück zum Zitat van den Bergh RCN, et al. Anxiety and distress during active surveillance for early prostate cancer. Cancer. 2009;115(17):3868–78.PubMedCrossRef van den Bergh RCN, et al. Anxiety and distress during active surveillance for early prostate cancer. Cancer. 2009;115(17):3868–78.PubMedCrossRef
43.
Zurück zum Zitat Arredondo SA, et al. Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE. J Urol. 2004;172(5):1830–4.PubMedCrossRef Arredondo SA, et al. Watchful waiting and health related quality of life for patients with localized prostate cancer: data from CaPSURE. J Urol. 2004;172(5):1830–4.PubMedCrossRef
44.
Zurück zum Zitat Vasarainen H, et al. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial. BJU Int. 2012;109(11):1614–9.PubMedCrossRef Vasarainen H, et al. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial. BJU Int. 2012;109(11):1614–9.PubMedCrossRef
45.
Zurück zum Zitat Goh AC, et al. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot stufy of men with prostate cancer who undergo active surveillance. BJU Int. 2011. Dec 7. doi: 10.1111/j.1464–410X.2011.10791.x. [Epub ahead of print]. Goh AC, et al. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot stufy of men with prostate cancer who undergo active surveillance. BJU Int. 2011. Dec 7. doi: 10.​1111/​j.​1464–410X.​2011.​10791.​x. [Epub ahead of print].
Metadaten
Titel
The Impact of Prostate Biopsy on Urinary Symptoms, Erectile Function, and Anxiety
verfasst von
Alexander P. Glaser
Kristian Novakovic
Brian T. Helfand
Publikationsdatum
01.12.2012
Verlag
Current Science Inc.
Erschienen in
Current Urology Reports / Ausgabe 6/2012
Print ISSN: 1527-2737
Elektronische ISSN: 1534-6285
DOI
https://doi.org/10.1007/s11934-012-0277-6

Weitere Artikel der Ausgabe 6/2012

Current Urology Reports 6/2012 Zur Ausgabe

Office Urology (N Shore, Section Editor)

Office Ultrasound for the Urologist

Office Urology (N Shore, Section Editor)

Optimal Prostate Biopsy Regimen

Benign Prostatic Hyperplasia (K McVary, Section Editor)

LUTS and Sleep Disorders: Emerging Risk Factor

Office Urology (N Shore, Section Editor)

A Reappraisal of Storage and Voiding Dysfunction

Office Urology (N Shore, Section Editor)

Male Genital Premalignant Dermatoses

Patrone im Penis bringt Urologen in Gefahr

30.05.2024 Operationen am Penis Nachrichten

In Lebensgefahr brachte ein junger Mann nicht nur sich selbst, sondern auch das urologische Team, das ihm zu Hilfe kam: Er hatte sich zur Selbstbefriedigung eine scharfe Patrone in die Harnröhre gesteckt.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.